ArticleBMC biotechnology2021

Expansion of targetable sites for the ribonucleoprotein-based CRISPR/Cas9 system in the silkworm Bombyx mori.

Yun-Long Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.